Gene therapy deals, clinical trials transparency and sartan medicine reviews… what’s new for pharma in business?

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

How a collaborative project aims to cut the cost of gene therapy

Mega mergers, state-of-the-art stem cell facility and humorous pharmaceutical ads… What’s new for pharma in business?

The 2018 Innovation Awards are here! From capsules, to software, to high-tech mass spectrometers; we celebrate the advances of the field.

Meet the companies and researchers protecting us from bioterrorists who plan to harness the destructive power of infectious diseases.

Extractables and leachables require rigorous analysis to protect patient safety.

A new gene therapy, a procurement process gone wrong, and backing away from a biosimilar…

Only 50 percent of clinical trial results in Europe are reported, but big pharma shares far less than half the blame.